¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bond strength"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dynamic strength
    1. µ¿Àû±Ù·Â 2. µ¿Àû°­µµ
  • ego strength
    ÀÚ¾ÆÈû
  • ionic strength
    À̿°­µµ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • physical strength
    ü·Â
  • strength
    1. ¼¼±â, °­µµ 2. Èû
  • strength duration curve
    °­µµ±â°£°î¼±
  • shearing strength
    Àü´Ü°­µµ, ¾ù°¥¸²¼¼±â
  • tearing strength
    Âõ±è°­µµ, Àο­°­µµ
  • ultimate strength
    ±ØÇѼ¼±â, ±ØÇѰ­µµ
  • wound strength
    â»ó°­µµ
  • wet strength
    ½ÀÀ±ÀÎÀå°­µµ
  • yield strength
    Ç׺¹°­µµ, Ç׺¹¼¼±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bonding strength
    °áÇÕÈû
  • strength duration curve
    °­µµ±â°£°î¼±
  • dynamic strength
    µ¿Àû±Ù·Â
  • ego strength
    ÀÚ¾ÆÈû
  • field strength
    ÀÚÀå¼¼±â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â, °¡ÀåÀÚ¸®ÀÚÀå¼¼±â
  • grasp strength
    Áã´ÂÈû
  • ionic strength
    À̿°­µµ
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • marginal strength
    °æ°è°­µµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â, ÃÖ°í±â¿ï±â¼¼±â
  • physical strength
    ü·Â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • multiple bond
    ´ÙÁß°áÇÕ(ÒýñìÌ¿ùê).
  • nonpolar bond
    ¹«±Ø¼º °áÇÕ(~Ì¿ùê).
  • nonpolar bond
    ºñ±Ø¼º °áÇÕ(~Ì¿ùê).
  • order of bond
    °áÇÕÂ÷¼ö(Ì¿ùêó¬â¦).
  • peptide bond
    ÆÕƼµå°áÇÕ
  • peptide bond
    ÆéŸÀ̵å°áÇÕ.
  • polar bond
    ±Ø¼º°áÇÕ(пàõÌ¿ùê).
  • semipolar bond
    ¹Ý±Ø¼º °áÇÕ(ÚâпàõÌ¿ùê).
  • triple bond
    »ïÁß°áÇÕ(¡­Ì¿ùê).
  • back strength
    ¹è±Ù·Â.
  • bending strength
    ±¼°î °­µµ(ÏÝÍØË­Óø).
  • bonding strength
    °áÇÕ·Â(Ì¿ùêæ³).
  • edge-strength
    ¿¬´Ü°­µµ(æÞӮ˭öô).
  • ego strength
    ÀÚ¾ÆÀÇ Èû
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dative bond
    "¹èÀ§°áÇÕ(ÛÕêÈÌ¿ùê), (ÔÒ) coordinate covalent bond"
  • dative covalent bond
    "¹èÀ§°øÀ¯°áÇÕ(ÛÕêÈÍìêóÌ¿ùê), (ÔÒ) coordinate covalent bond"
  • distorted bond model
    ¿Ö°î°áÇÕ(èàÍØÌ¿ùê) ¸ðµ¨
  • disulfide bond
    ÀÌȲ°áÇÕ(ì£üÜÌ¿ùê)
  • double bond
    ÀÌÁß°áÇÕ(ì£ñìÌ¿ùê)
  • electron pair bond
    ÀüÀÚ½Ö °áÇÕ(ï³í­äªÌ¿ùê)
  • electrostatic bond
    Á¤Àü±â °áÇÕ(ð¡ï³Ñ¨Ì¿ùê)
  • energy-rich bond
    ºÎ(Ý£)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • equatorial bond
    ¼öÆò¹æÇâ °áÇÕ (â©øÁÛ°ú¾Ì¿ùê)
  • exocyclic bond
    °í¸®¹Û °áÇÕ(Ì¿ùê)
  • glycosidic bond
    ±Û¶óÀÌÄÚ»çÀÌµå °áÇÕ(Ì¿ùê)
  • heterologous bond
    À̺ÎÀ§ °áÇÕ(ì¶Ý»êÈÌ¿ùê)
  • high-energy bond
    °í(ÍÔ)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • hydrogen bond
    ¼ö¼Ò °áÇÕ(â©áÈÌ¿ùê)
  • hydrophobic bond
    ¼Ò¼ö °áÇÕ(áÂâ©Ì¿ùê)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VB vaginal bulb; valence bond; venous blood; ventrobasal; Veronal buffer; vertebrobasilar; viable birth...
BS Bachelor of Science; Bachelor of Surgery; Bacillus subtilis; Bartter syndrome; base strap; bedside; ...
FS factor of safety; Fanconi syndrome; Felty syndrome; fibromyalgia syndrome; field stimulation; Fisher...
GS gallstone; Gardner syndrome; gastric shield; general surgery; gestational score; Gilbert syndrome; g...
HS Haber syndrome; half strength; hamstring; hand surgery; Hartmann solution; head sling; healthy subje...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DTS Diametral tensile strength
ES Ego Strength
HGS Handgrip strength
IS Ionic Strength
LISS Low ionic strength solutions
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
  • fracture strength
    ÆÄÀý °­µµ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • margin strength
    º¯¿¬ °­µµ
    °­µµ¶õ ¾î¶² ¹°Ã¼¸¦ ÆÄ°ú½Ã۴µ¥ ÇÊ¿äÇÑ ÃÖ´ëÀÇ ÀÀ·ÂÀ¸·Î¼­ Àη¹ÀÌ ÁöÀ۽à marginal ridge ºÎÀ§¿¡ »ç¿ëµÇ´Â Àç·áÀÇ °­µµ¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î º¯¿¬°­µµ°¡ Å« Àç·áÀÎ °æ¿ì¿¡´Â cavo-surface angleÀº µÐ°¢ÀÌ µÇ°í ±× ¹Ý´ëÀÎ °æ¿ì¿¡´Â Á÷°¢¿¡ °¡±õ°Ô Çü¼ºÇØÁØ´Ù.
  • marginal strength
    º¯¿¬ °­µµ, ¿¬´Ü °­µµ
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • physical strength
    ü·Â
  • shear strength
    Àü´Ü °­µµ
    µÚƲ¸®´Â Èû ¶Ç´Â Á¢¼±À» µû¶ó ¿òÁ÷ÀÌ´Â Èû¿¡ ÀúÇ×ÇÏ´Â ¼ºÁú.
  • shear tensile strength test
    Àü´Ü ÀÎÀå °­µµ ½ÃÇè
  • shearing strength
    Àü´Ü °­µµ
  • tearing strength
    Àο­µµ
  • ultimate strength
    ±ØÇÑ °­µµ, ÃÖÁ¾ °­µµ, ÃÖ°­µµ
    1. ÀÀ·Â-º¯Çü·ü °î¼±¿¡¼­ ³ªÅ¸³ª´Â ÃÖ´ë°­µµ. 2. ÀÀ·Â-º¯ÇüÀ² ±×¸²»óÀÇ ¿Ü°ü»ó ÃÖ´ë ÀÀ·Â. ÇÏÁßÀÇ Á¾·ù¿¡ µû¶ó ÀÎÀå °­µµ, ¾ÐÃà °­µµ, Àü´Ü °­µµ µîÀ¸·Î ±¸º°µÈ´Ù.
  • wet strength
    ½ÀÀ±µµ, ½À°­µµ
    ¹Ý¼öÈ­¹°¿¡ ÇÊ¿äÇÑ ¼öÈ­ Á¤µµ ÀÌ»óÀ¸·Î °úÇÏ°Ô ¼öºÐÀÌ Á¸ÀçÇÏ´Â ½ÃÆí¿¡ À־ÀÇ °­µµ. ¼®°í ÁÖÀÔ ÈÄ 1½Ã°£ °æ°ú ÈÄÀÇ °­µµ¸¦ ¶æÇÑ´Ù. dry strengthº¸´Ù 2¹è °­µµ°¡ ¶³¾îÁø´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
bond dissociation energy This is the energy needed to break the bonds between two linked atoms.
(09 Oct 1997)
bond energy The energy needed to break a molecular bond.
(09 Oct 1997)
bond length This is the distance between the nuclei of two atoms which have formed bonds with each other.
(09 Oct 1997)
bufenolides (one double bond) (05 Mar 2000)
carbon-carbon double bond isomerases <enzyme> Enzymes that catalyze the shifting of a carbon-carbon double bond from one position to another within the same molecule.
Registry number: EC 5.3.3
(12 Dec 1998)
pair bond In animals, the social relationship established between a male and female for reproduction. It may include raising of young.
(12 Dec 1998)
glycosidic bond <biochemistry> A bond between a sugar andanother organic molecule by way of anintervening nitrogen or oxygen atom.
(09 Oct 1997)
peptide bond The amide linkage between the carboxyl group of one amino acid and the amino group of another. The linkage does not allow free rotation and can occur in cis or trans configuration, the latter the most common in natural peptides, except for links to the amino group of proline, which are always cis.
(18 Nov 1997)
chemical bond The link between two atoms within a molecule. Different types of chemical bonds include hydrogen bonds, covalent bonds, and ionic bonds.
(09 Oct 1997)
phosphodiester bond <chemistry> Not a precise term. Refers to any molecule in which two parts are joined through a phosphate group.
Examples are found in RNA, DNA, phospholipids, cyclic nucleotides, nucleotide diphosphates and triphosphates.
(18 Nov 1997)
pi bond <chemistry> A bond formed from the overlap of two parallel p-orbitals.
(09 Jan 1998)
coordinate covalent bond A bond in which the two electrons shared by a pair of atoms belonged originally to only one of the atoms; often represented by a small arrow pointing toward the electron receiver; e.g., nitric acid, O(OH)N&rarr;O; phosphoric acid, (OH)3P&rarr;O.
Synonym: coordinate covalent bond.
(05 Mar 2000)
covalent bond A bond between two or more atoms that is provided by electrons that travel between the atoms' nuclei, holding them together but keeping them a stable distance apart.
(09 Oct 1997)
heteropolar bond Bond between atoms or groups carrying opposite charges (or, in some cases, partial charges).
Synonym: heteropolar bond, salt bridge.
(05 Mar 2000)
high energy bond <chemistry> Chemical bonds that release more than 25kJ/mol on hydrolysis: their importance is that the energy can be used to transfer the hydrolysed residue to another compound. The risk in using the term is that students may think the bond itself is different in some way, whereas it is the compound that matters. Hydrolysis of creatine phosphate yields 42.7kJ/mol, of phosphoenolpyruvate, 53.2, ATP to ADP, 30.5: the latter is important because it shows that energetically the hydrolysis of creatine phosphate will suffice to reconstitute ATP, hence the use of creatine phosphate in muscle.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • erasable bond
    ÀÌ·¹ÀÌÀúºí º»µåÁö(½±°Ô Áö¿ï ¼ö ÀÖ°Ô ÇÑ ÄÚµùÁö)
  • exchequer bond
    ±¹°íä±Ç
  • fiduciary bond
    ¼öŹÀÚ º¸Áõ
  • general obligation bond
    ÀÏ¹Ý º¸ÁõÁ¦(¿ø±Ý°ú ÀÌÀÚ ÁöºÒÀÌ º¸ÁõµÇ¾î ÀÖ´Â Áö¹æÁ¤ºÎä)
  • government bond
    ±¹Ã¤
  • ionic bond
    (È­)À̿ °áÇÕ
  • pair bond
    ¾Ï¼ö 1´ë 1ÀÇ °ü°è 
  • performance bond
    °è¾à ÀÌÇà º¸Áõ¿ë ±ÝÀü 乫 Áõ¼­
  • preference bond
    ¿ì¼± Á¤ºÎ °øÃ¤
  • premium (savings) bond
    ÇÒÁõ±ÝÀÌ ºÙÀº ä±Ç
  • premium on bond
    ȸ»çä ¹ßÇà Â÷±Ý
  • purchasing power bond
    ±¸¸Å·Â ä±Ç(±¸¸Å·ÂÀ» ³ªÅ¸³»´Â Áö¼ö¿¡ ¿¬µ¿½ÃÄÑ ÀÌÀÚ,»êȯ¾×À» º¯µ¿ÄÉ ÇÏ´Â °Í)
  • ransom bill(bond)
    ³ªÆ÷ ¼±¹ÚÀÇ ¹è»ó Áõ¼­
  • registered bond
    ±â¸í °øÃ¤(¼ÒÀ¯ÀÚÀÇ À̸§ÀÌ ÀûÈù)
  • revenue bond
    ¼¼ÀԴ㺸ä
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á